🔗 Share this article

The top legal official in Texas Ken Paxton is taking legal action against the makers of Tylenol, asserting the companies concealed potential risks that the drug posed to pediatric neurological development.

This legal action arrives thirty days after President Donald Trump publicized an unsubstantiated connection between consuming Tylenol - also known as paracetamol - during pregnancy and autism in children.

Paxton is taking legal action against the pharmaceutical giant, which previously sold the drug, the exclusive pain medication suggested for pregnant women, and Kenvue, which now manufacturers it.

In a official comment, he stated they "betrayed America by profiting off of discomfort and pushing pills regardless of the potential hazards."

Kenvue states there is lacking scientific proof tying acetaminophen to autism spectrum disorder.

"These corporations misled for generations, knowingly endangering countless individuals to boost earnings," Paxton, from the Republican party, said.

The company said in a statement that it was "deeply concerned by the perpetuation of misinformation on the reliability of acetaminophen and the potential impact that could have on the welfare of women and children in America."

On its official site, the company also mentioned it had "regularly reviewed the pertinent research and there is no credible data that indicates a proven link between consuming paracetamol and autism."

Organizations representing doctors and medical practitioners share this view.

The American College of Obstetricians and Gynecologists has declared acetaminophen - the primary component in acetaminophen - is one of the few options for women during pregnancy to treat discomfort and fever, which can create significant medical dangers if left untreated.

"In multiple decades of research on the utilization of paracetamol in pregnancy, no reliable research has conclusively proven that the consumption of acetaminophen in any trimester of pregnancy causes neurodevelopmental disorders in children," the organization stated.

The court filing cites recent announcements from the former administration in arguing the drug is allegedly unsafe.

Recently, the former president generated worry from health experts when he advised expectant mothers to "struggle intensely" not to take Tylenol when unwell.

The FDA then released a statement that medical professionals should contemplate reducing the usage of Tylenol, while also mentioning that "a direct connection" between the drug and autism spectrum disorder in children has remains unverified.

The Health Department head Robert F Kennedy Jr, who manages the Food and Drug Administration, had promised in April to initiate "a massive testing and research effort" that would determine the cause of autism spectrum disorder in a matter of months.

But specialists cautioned that identifying a sole reason of autism spectrum disorder - believed by scientists to be the result of a intricate combination of inherited and environmental factors - would prove challenging.

Autism spectrum disorder is a type of enduring cognitive variation and disability that influences how persons encounter and interact with the world, and is diagnosed using physician assessments.

In his legal document, Paxton - a Trump ally who is seeking the Senate - alleges Kenvue and J&J "willfully ignored and tried to quiet the evidence" around acetaminophen and autism spectrum disorder.

This legal action attempts to require the firms "eliminate any marketing or advertising" that asserts Tylenol is reliable for women during pregnancy.

This legal action parallels the concerns of a group of parents of minors with autism and attention deficit hyperactivity disorder who filed suit against the producers of Tylenol in 2022.

Judicial authorities threw out the lawsuit, stating research from the parents' expert witnesses was lacking definitive proof.